Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease

April 2013

Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease.

It's for patients with pituitary tumors...when surgery isn't an option or isn't effective.

It's an injectable somatostatin analogue that suppresses the release of ACTH (adrenocorticotropic hormone).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote